Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Combining laser therapy with platelet-rich plasma improves hair growth in people with hair loss.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Balding and low testosterone increase risk of urinary stones.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Combining laser therapy with other treatments effectively increases hair density and thickness for hair loss.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.